Expert Opinion on Therapeutic Patents

New directions in the treatment of anxiety disorders
pp. 401-423(23)
Authors: Hood S.D.; Argyropoulos S.V.; Nutt D.J.

Novel antipsychotic agents: recent advances in the drug treatment of schizophrenia
pp. 425-448(24)
Authors: Butini S.; Campiani G.; Angelis M.D.; Fattorusso C.; Nacci V.; Fiorini I.

Therapeutic strategies in Huntington’s disease
pp. 449-465(17)
Authors: Alberch J.; Canals J.M.; Pérez-Navarro E.

Patents on tetracycline and tetracycline derivatives as antimicrobials: January 1998 – October 2002
pp. 467-478(12)
Authors: Podlogar B.L.; Ohemeng K.A.; Barrett J.F.

Novel microsomal triglyceride transfer protein inhibitors
pp. 479-488(10)
Authors: Williams S.J.; Best J.D.

An overview of plant extracts as potential therapeutics
pp. 489-497(9)
Author: Gibbons S.

Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes
pp. 499-510(12)
Authors: Augustyns K.; Van der Veken P.; Senten K.; Haemers A.

Annotated Patent Selections
pp. 511-545(35)

HIV protease inhibitors based on amino acid derivatives
pp. 547-550(4)

Novel guanidino compounds
pp. 551-555(5)

New steroids and steroid–longacting ₂agonist combinations
pp. 557-561(5)